Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 2007

View Archived Issues

Recent patents describe new analgesic agents

Novel treatments for immunological diseases claimed in recent patent literature

Fresenius Kabi to acquire Kyorin's blood volume replacement business

Novel therapeutic strategies for cancer covered in recent patent literature

Targeting the sodium pump alpha1 subunit shows promising results in NSCLC

Preclinical profile of the c-Met inhibitor ARQ-197 reported by ArQule

Novel c-Met inhibitor presented at the AACR meeting

New somatostatin receptor ligand shows antitumor activity in vivo

Vascular disrupting activity of MPC-6827 alone or in combination with carboplatin

New Canadian approval for Lipitor

BMS and Pfizer collaborate on anticoagulant and metabolic compounds

FDA approves IND for M6G

Lexicon Genetics changes name to Lexicon Pharmaceuticals

SB-509 begins new phase II study in moderate to severe diabetic neuropathy

Nuvion advanced into second pivotal study in steroid-refractory ulcerative colitis

Novagali cleared to begin U.S. phase III study of Nova-22007

Prochieve shows possible effect in delaying cervical shortening

Humira recommended for E.U. approval for Crohn's disease

Invega recommended for European approval

New approvable letter for CIP-Isotretinoin

U.K. launch for Prezista

Byetta launched in U.K.

Januvia launched in U.K.

Advagraf receives E.U. approval

Non-approvable letter for Arcoxia

Novartis' Optaflu recommended for E.U. approval

CHMP hands down negative opinion on Genasense for melanoma

Novel Amgen c-Met inhibitors reported to be active against multiple mutations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...